clinical trial · NCT04969822
eValuating iDA Selection Ability. The VISA Study.
Vitrolife·N/A·completed·n = 1,066
IVFInfertilityiDAScore®
brief summary
A non-inferiority, prospective parallel group, multi-center, randomized controlled trial to investigate whether selection of a single blastocyst for transfer using the deep learning tool, iDA, results in non-inferior clinical pregnancy rate compared to trained embryologists using standard morphology criteria.
started
Feb 20, 2020
primary completion
Jan 24, 2023
completion
Nov 1, 2023
last updated
Dec 2, 2024
official title
Will Embryo Selection Through Use of Artificial Intelligence (iDA) Perform Equally Compared to Day 5 Morphology?
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol